Dr. Borriello will be a featured speaker at an upcoming live webinar entitled “Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as the ‘Next Big Thing’ in Cancer Immunotherapy”.
The live webinar, being moderated by Lumanity, will bring together a diverse array of biotech with a range of platforms and modalities to modulate innate pathways towards the goal of enhancing the ability of the patient’s immune system to control cancer (with or without immune checkpoint inhibitors).
Date: Wednesday, October 23, 2024
At: 10:30 a.m. Eastern Daylight time
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
